High throughput isolation and glycosylation analysis of IgG–variability and heritability of the IgG glycome in three isolated human populations M Pučić, A Knežević, J Vidič, B Adamczyk, M Novokmet, O Polašek, ... Molecular & Cellular Proteomics 10 (10), 2011 | 587 | 2011 |
Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers G Lauc, JE Huffman, M Pučić, L Zgaga, B Adamczyk, A Mužinić, ... PLoS genetics 9 (1), e1003225, 2013 | 438 | 2013 |
Glycans are a novel biomarker of chronological and biological ages J Krištić, F Vučković, C Menni, L Klarić, T Keser, I Beceheli, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2014 | 428 | 2014 |
Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans A Knežević, O Gornik, O Polašek, M Pučić, I Redžić, M Novokmet, ... Glycobiology 20 (8), 959-969, 2010 | 306 | 2010 |
Genomics meets glycomics—the first GWAS study of human N-glycome identifies HNF1α as a master regulator of plasma protein fucosylation G Lauc, A Essafi, JE Huffman, C Hayward, A Knežević, JJ Kattla, ... PLoS genetics 6 (12), e1001256, 2010 | 303 | 2010 |
Glycosylation of serum proteins in inflammatory diseases O Gornik, G Lauc Disease markers 25 (4-5), 267-278, 2008 | 303 | 2008 |
Variability, heritability and environmental determinants of human plasma N-glycome A Knezevic, O Polasek, O Gornik, I Rudan, H Campbell, C Hayward, ... Journal of proteome research 8 (2), 694-701, 2009 | 286 | 2009 |
Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome F Vučković, J Krištić, I Gudelj, M Teruel, T Keser, M Pezer, ... Arthritis & rheumatology 67 (11), 2978-2989, 2015 | 272 | 2015 |
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ... Nature communications 7 (1), 13507, 2016 | 248 | 2016 |
Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome I Trbojević Akmačić, NT Ventham, E Theodoratou, F Vučković, ... Inflammatory bowel diseases 21 (6), 1237-1247, 2015 | 214 | 2015 |
Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research JE Huffman, M Pučić-Baković, L Klarić, R Hennig, MHJ Selman, ... Molecular & Cellular Proteomics 13 (6), 1598-1610, 2014 | 210 | 2014 |
Stability of N-glycan profiles in human plasma O Gornik, J Wagner, M Pučić, A Knežević, I Redžić, G Lauc Glycobiology 19 (12), 1547-1553, 2009 | 193 | 2009 |
Alternative glycosylation modulates function of IgG and other proteins—implications on evolution and disease O Gornik, T Pavić, G Lauc Biochimica et Biophysica Acta (BBA)-General Subjects 1820 (9), 1318-1326, 2012 | 175 | 2012 |
Changes in IgG and total plasma protein glycomes in acute systemic inflammation M Novokmet, E Lukić, F Vučković, Ž –Durić, T Keser, K Rajšl, ... Scientific reports 4 (1), 4347, 2014 | 173 | 2014 |
Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases M Šimurina, N de Haan, F Vučković, NA Kennedy, J Štambuk, D Falck, ... Gastroenterology 154 (5), 1320-1333. e10, 2018 | 156 | 2018 |
Mutations in HNF1A result in marked alterations of plasma glycan profile G Thanabalasingham, JE Huffman, JJ Kattla, M Novokmet, I Rudan, ... Diabetes 62 (4), 1329-1337, 2013 | 137 | 2013 |
Comparison of 2-Aminobenzamide, Procainamide and RapiFluor-MS as Derivatizing Agents for High-Throughput HILIC-UPLC-FLR-MS N-glycan Analysis T Keser, T Pavić, G Lauc, O Gornik Frontiers in Chemistry 6, 324, 2018 | 133 | 2018 |
IgG glycan patterns are associated with type 2 diabetes in independent European populations RFH Lemmers, M Vilaj, D Urda, F Agakov, M Šimurina, L Klaric, I Rudan, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (9), 2240-2249, 2017 | 126 | 2017 |
Altered N‐glycosylation profiles as potential biomarkers and drug targets in diabetes N Rudman, O Gornik, G Lauc FEBS letters 593 (13), 1598-1615, 2019 | 123 | 2019 |
Glycosylation of immunoglobulin g: role of genetic and epigenetic influences C Menni, T Keser, M Mangino, JT Bell, I Erte, I Akmačić, F Vučković, ... PloS one 8 (12), e82558, 2013 | 123 | 2013 |